First-line Immuno-chemotherapy for extensive-stage small-cell lung cancer: A network meta-analysis and cost-effectiveness analysis

INTRODUCTION: Many randomized controlled trials have indicated that immuno-chemotherapy could generate clinical benefits, though the cost of immuno-chemotherapy was so prohibitive and the options were varied. This investigation aimed at evaluating effectiveness, safety, and cost-effectiveness for im...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Youwen, Liu, Kun, Yang, Qiuping, Zeng, Manting, Peng, Libo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061061/
https://www.ncbi.nlm.nih.gov/pubmed/37006537
http://dx.doi.org/10.3389/fpubh.2023.1028202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061061/
https://www.ncbi.nlm.nih.gov/pubmed/37006537
http://dx.doi.org/10.3389/fpubh.2023.1028202

Ejemplares similares